Europe Noninvasive Ventilation Masks Market Trends by 2030

The Europe noninvasive ventilation masks market size is projected to reach US$ 1,076.68 million by 2030 from US$ 719.83 million in 2022; the Europe noninvasive ventilation masks market is expected to register a CAGR of 5.2% during 2022–2030.

Market Insights and Analyst View:

Noninvasive ventilation (NIV) is the delivery of oxygen (ventilation support) through a face mask, eliminating the need for an endotracheal airway. NIV provides comparable physiological benefits to conventional mechanical ventilation by reducing breathing work and improving gas exchange. The intervention is recognized as an effective treatment for respiratory failure in chronic obstructive pulmonary disease (COPD), cardiogenic pulmonary edema, and other respiratory conditions without complications such as upper airway trauma, ventilator-associated pneumonia, respiratory muscle weakness, and sinusitis. Thus, the increasing prevalence of respiratory diseases significantly impacts the Europe noninvasive ventilation masks market growth.

Growth Drivers and Challenges:

Rising prevalence of chronic obstructive pulmonary diseases (COPD) and respiratory disease in Europe fuels the Europe noninvasive ventilation masks market growth. COPD is one of the most significant public health concerns. According to an article titled “Effectiveness of a home telemonitoring program for patients with chronic obstructive pulmonary disease in Germany” published by the National Library of Medicine in 2022, Germany reported ∼ 6 million COPD cases. According to an article titled “What knows a frail Swiss population about chronic obstructive pulmonary disease?” published in 2021, about 400,000 people were affected by COPD in Switzerland.

Patients with underlying COPDs who suffer from exacerbation of their diseases and hypercapnic dyspnoea or respiratory failure are most likely to be successfully treated with noninvasive ventilation (NIV). NIV effectively relieves the pressure on the respiratory muscles, increases tidal volume, decreases respiratory rate, and reduces the work of diaphragmatic breathing, resulting in an improvement in oxygen supply, a decrease in hypercapnia, and an improvement in dyspnea. A COPD is ideal for NIV as the treatment is quickly reversible, and additional support can be provided.

NIV reduces the endotracheal intubation rate, length of hospital stays, complications of mechanical ventilation, and mortality for COPD patients. Recent clinical practice guidelines recommend NIV as first-line ventilatory support for treating acute respiratory failure (ARF) in COPD. NIV masks are increasingly used to treat people suffering from COPD and respiratory failure.

NIV helps reduce intubation and mortality in patients affected by COPD exacerbation with respiratory failure. The type of mask may impact the success rate. A full-face mask is recommended over nasal masks for patients who are seriously ill and suffer from ARF. Thus, the increasing prevalence of COPD and other respiratory disorders in Europe fuels the Europe noninvasive ventilation masks Europe noninvasive ventilation masks market market growth. Further,

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Europe Noninvasive Ventilation Masks Market: Strategic Insights

Market Size Value in	US$ 719.83 million in 2022
Market Size Value by	US$ 1,076.68 million by 2030
Growth rate	CAGR of 5.2% from 2022 to 2030
Forecast Period	2022-2030
Base Year	2022

Mrinal

Have a question?

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

 Speak to Analyst

Future Trend:

Technological advancements in NIV mask products are expected to bring new Europe noninvasive ventilation masks market trends in the coming years. NIV is the standard care for patients suffering from breathing or sleep-breathing disorders. Technological advancements enable the development of newer modes of automatic NIV adjustment suitable for patients affected by complex breath abnormalities that may be challenging to manage with traditional positive airway pressure therapy effectively. These modes allow stable ventilation when ventilation demands fluctuate. CPAP applies continuous positive airway pressure to non-intubated adult or pediatric patients. It can be used on spontaneously breathing patients who require short-term mechanical assistance. The effectiveness of the treatment is related to the correct sealing of the nasal or full face mask on the patient's face.

The choice of interface is one of the most critical steps for the success of NIV. While developing masks, companies pay great attention to shape, materials, comfort, and leakage reduction. However, the constant evolution of new products increases the availability of interfaces and the ability to meet different requirements. The alternating use of other interfaces can remain an excellent strategy for patients requiring several hours of NIV daily, both in the acute and chronic home environment, to reduce the risk of skin damage and improve patient tolerance. ResMed has offered an intelligent NIV mask that can help tailor treatment to patients' unique and changing needs. Increasing collaborations and R&D investments in the development of technologically advanced products are intended to stimulate the growth of the Europe noninvasive ventilation masks market in the coming years.

Segmental Analysis:

The Europe noninvasive ventilation masks market analysis has been carried out by considering the following segments: interfaces, application, usage, material, size, product type, and end user.

By interfaces, the market is bifurcated into masks and accessories. The masks segment consists of a nasal mask, face mask, nasal pillow mask, oral mask, and total face mask/helmet. Face mask is further sub-segmented into CO2-venting face masks and non-vented face masks. Accessories of NIV masks include elbows and replacement elbows, hoses, tubes, skin barriers, under/over the nose cushions, and head strap/replacement gears. The masks segment consists of nasal mask, face mask, nasal pillow mask, oral mask, and total face mask/helmets. The nasal mask has a triangle structure and is worn around the nose. Four-point headgear that attaches to the frame is typically used to hold the nasal mask in place. The use of nasal mask can irritate the bridge of the nose, where the mask rests. Nasal pillows are cushioning that seal at the base of the nostril and are help in place with a stretchy strap that goes around the back of the head. Nasal pillows fit at the nostrils to supply air pressure.

Full face masks cover the entire face, including the nose and lips. Some have a forehead stabilizer that helps active sleepers get a better cushion seal. The headgear usually has four contact points for stability and easier adjustments. Some manufacturers have lately altered full face masks to sit beneath the user's nose. These designs significantly limit facial contact and reduce the claustrophobia experienced by certain full face mask users.

Total face masks are held in place by four-point headgear and sealed in a broad oval around the complete face to enclose the nose, mouth, and eyes. When receiving treatment for Sleep Apnea, some patients experience a leak of air from the corners of their eyes. Other masks will not operate correctly if this occurs, and a total face mask should be considered. Facial issues can prevent patients from wearing a nasal or full-face mask. A total face mask, like a full-face mask, equalizes the pressure so that the air treatment is consistent, but it also covers the entire face and any areas where air could escape, such as the eyes.

Oral masks use an oval-shaped mask cushion to deliver airflow to the mouth only. These masks are a great alternative to full face masks. It works by creating a seal around the mouth and delivering air through two inlets inside the mask. This method is ideal for those who breathe through their mouth at night

The scope of Europe noninvasive ventilation masks market report includes the assessment of the market performance in the UK, Germany, France, Austria, Switzerland, and the Rest of Europe.

Europe Noninvasive Ventilation Masks Market Share, by Product Type – 2022 and 2030

Regional Analysis:

Geographically, the Europe noninvasive ventilation masks market is segmented into the UK, Germany, France, Austria, Switzerland, and the Rest of Europe. Germany is the biggest contributor to the market. Noninvasive ventilation is widely used in acute care settings for acute respiratory failure (ARF) across a variety of aetologies. According to an article titled “Effectiveness of a home telemonitoring program for patients with chronic obstructive pulmonary disease in Germany” published by the National Library of Medicine in 2022, Germany records ~6 million COPD cases. NIV effectively relieves the pressure on respiratory muscles, increases the tidal volume, decreases the respiratory rate, and reduces the work of diaphragmatic breathing, resulting in an improvement in oxygen supply, a decrease in hypercapnia, and an improvement in dyspnea. NIV masks is ideal for COPD as the treatment is quickly reversible, and additional support can be provided. Thus, the increase in the prevalence of COPD in Germany fuels the non-invasive ventilation masks market growth in Germany.

Reimbursement policies for medical devices also determine the Europe noninvasive ventilation masks market growth in Germany. NIV masks treatment costs used in intensive care unit (ICU) are reimbursed in the country, and patients have to pay amounts out of their pockets in in-home cases. Favorable reimbursement scenario during hospitalization in Germany drives the growth of the Germany noninvasive ventilation masks market.

Competitive Landscape and Key Companies:

Fisher & Paykel Healthcare Ltd, Armstrong Medical Ltd, Intersurgical Ltd, Hamilton Medical, ResMed, Koninklijke Philips NV, Ambu AS, Dragerwerk AG & Co KGaA, DEAS S.R.L, and SunMed Group Holdings LLC are among the prominent players profiled in the Europe noninvasive ventilation masks market report. In addition, several other players have been studied and analyzed during the study to get a holistic view of the market and its ecosystem. These companies focus on geographic expansions and new product launches to fulfill the growing demand from consumers worldwide and increase their product range in specialty portfolios. Their presence allows them to serve a large customer base, subsequently facilitating the Europe noninvasive ventilation masks market expansion.